www.ceapro.comTSX: CZO

Enhancing Life Through Nature

Corporate PresentationApril 2016

Forward Looking Statements

This presentation contains forward-looking statements. Various factors could cause actual results to differ materially from those projected in forward-looking statements, including those predicting the timing of product development and launches. Although the company believes that the forward-looking statements contained herein are reasonable, it can give no assurance that the Company’s expectations are correct.

All forward-looking statements are expressly qualified by this Cautionary Statement.

2

Corporate Overview

Focused on the development and commercialization of active ingredients for healthcare and cosmetic industries

- Unrivaled, proprietary plant extraction based manufacturing process

Two active ingredients currently used in multiple household name products –cosmetics & personal care

- Beta Glucan

- Avenanthramides

Revenue generating, de-risked business model supports near-term and future growth

- Highest revenues, profits and cash flows reported in Company’s history for FY 2015

Unique Pressurized Gas Expanded (PGX) enabling technology with the potential to address broad range of industries

Robust growth strategy with near-term potential to expand into nutraceutical, OTC and pharma markets

3

Core Expertise

Identification, extraction and purification of active compounds from natural sources

Create innovative ingredients for the personal and healthcare industries

4

From Field to Formulation

5

Field

Identify

Unique

Plants

Research

Discover

Novel Functional

Actives

Manufacturing

Develop

Innovative

Processes

Consumer

Provide

Innovative

Products

Unique Bioprocessing Expertise

Ability to isolate and purify specific molecules from a wide range of botanical sources

Prototype extracts are then prepared for bio-screening or in vivo testing

Unique drying (heat-free) technology for sensitive compounds

Commercialized unique bio-actives from several botanical sources

Ability to take concept to commercialization in a relatively short period of time

6

New & Innovative Technologies

7

Pressurized Gas Expanded (PGX) Technology

Proprietary Plant Extraction Based Manufacturing

8

Lupinus angustifolia

and

Avena sativa

Lead Active Ingredients

Beta Glucan

Avenanthramides

Beta Glucan and Avenanthramidesin Multiple Household Name Products

Aveeno

Jergens

Lubriderm

3M – Nexcare

KY Products

Neutrogena

9

Coppertone

Dove

Burt’s Bees

The Body Shop

Philosophy

ROC

Financial Performance 2012-2015

-2

0

2

4

6

8

10

12

2012 2013 2014 2015

Revenue, ($M) Income (loss) from operations, $000000

10

Opportunity to Expand into Multiple Markets

11

Cosmeceuticals Nutraceuticals Pharmaceuticals

Fueling Our Pipeline

12

Pre-Clinical Clinical Market

Beta Glucan

Cosmetics and

Personal Care

Functional Drink

Cholesterol

Avenanthramides

Cosmetics and

Personal Care

Exercised Induced

Inflammation

Beta Glucan

Beta glucan is a water soluble fibre found in the cell walls of oat kernels

Acts as a natural moisture barrier and film-forming agent

Relieves and alleviates dry and itchy skin by replenishing and protecting the skin’s moisture barrier

Provides hydration against the drying effects of the sun

Smoothens wrinkles, reducing the visible signs of aging

13

Beta Glucan in Cosmeceuticals

Ceapro was the first to demonstrate that high molecular weight beta glucan can penetrate human skin

Dermatology applications range from anti-ageing to wound healing

New highly purified beta glucan powder successfully developed to address new market demands/trends

14

Natural Skin Restructuring Agent

Proven to effectively reduces fine lines & wrinkles

Forms a natural barrier protecting skin

Wound healing agent – films or gels

Sustained release of active agents requiring enhanced percutaneous transportation

15

Beta Glucan in Nutraceuticals and Pharmaceuticals

Potential reduction of cardiovascular and heart diseases risk - Acts to decrease LDL and total cholesterol

Proprietary beta glucan drug-delivery platform- Shown to effectively penetrate into the skin, into the deep layers as well

as into the skin cells

- Uses ranging from wound care and therapy, to skin care treatments that reduce the signs of aging

16

Unique Enabling Technology - PGX

Pressurized Gas Expanded (PGX) Liquid – Spray Drying

PGX is a novel spray drying technique for processing water-soluble biopolymers

- Platform that can produce numerous morphologies of biopolymers ranging from fine fibres to granular powder, which are highly water soluble

Operates at lower temperatures than conventional spray drying allowing incorporation of thermosensitive bioactives as well

17

PGX-BG Impregnated with CoQ10 (iBG)

Impregnation of highly porous biopolymer matrix - with thermosensitive bioactives (or

drugs, API) - Nutraceuticals- Functional food ingredients

- Drug Delivery Vehicle

Impregnation is accomplished- by means of supercritical CO2

- in the same processing equipment - at moderate temperatures of 40 °C.

Pure PGX BG

iBG: 5.5% CoQ10 on BG

18

CNC Before and After PGX Drying

Production of biomaterials from different industries

19

0.5 g CNCSpray Dried

0.5 g CNCPGX Dried

CNC AEROGELDensity : 0.006 g/cm3

Impregnation of PGX-GA with b-Carotene

20

PGX - A New Platform Technology

Application of PGX-CNC- Wound healing, scaffolds

- Drug delivery- Absorbents- Composite-plastic- Paints

PGX processing allows processing of high value biopolymers- Beta Glucan- Chitosan- Gum Arabic- CNC

21

Avenanthramides

Antihistamine and anti-inflammatory properties

Potential benefits in the control of inflammation-based diseases

22

Avenanthramides Clinically Proven in Cosmeceuticals

Significant improvements in erythema symptoms associated in subjects with mild to moderate atopic dermatitis- 40% improvement in itch perception after

1 week

- 62% of patients showed an improvement in their skin condition

Subjects with atopy- 89% of subjects saw significant

improvement in itch after 1 week

- Continued improvement after 4 weeks

23

Advanced Skin Care

Skin inflammation is a complex physiological process

Beta Glucan- Accelerates tissue healing

- Deep hydrating agent

- Improves elasticity

- Natural film protective barrier

Avenanthramides- Relief from itching (Pruritus)

- Reduces inflammation and swelling

- Reduces redness (erythema)

24

Beta glucan

Avenanthramides

Avenanthramides in Nutraceuticals and Pharmaceuticals

Avenanthramides shown to attenuate exercise-induced

inflammation in animal studies

Human clinical studies showed that dietary avenanthramides

supplements significantly reduced inflammation biomarkers in

both elderly and young population

New process technology licensed from Agriculture and Agri-

Food Canada (AAFC) enables production of high concentration

of AVAs

25

Strategy Designed to Leverage Enabling Technologies

26

Cosmeceuticals

• Generate scientific data to support current product indications

• Pursue new indications for current product portfolio from research programs

• Develop new products in accordance with needs expressed by customers

• Improve manufacturing technologies

• Look for ability to develop co-products

Nutraceuticals

• Produce 2nd generations of current products (higher concentrations, powder versions, etc)

• Capture bigger margins

Pharmaceuticals

• Produce 3rd generations of current products (higher concentrations, powder versions, etc)

• Conduct formulation work and assess potential for pharmaceutical development

Value Drivers

Cosmeceuticals - Current and new indications - Base business

Nutraceuticals - New product development - Near term catalyst

Pharmaceuticals - New products, new partnership discussions

Manufacturing Innovation - New processes, higher output, lower cost

27

New Bio-Processing Facility

28

R&D

Pilot Scale Capability

Commercial Production

New 30,000 sq. ft. GMP Bio-processing Extraction Facility in Edmonton,

Alberta, Canada

Financial Profile

29

TSX-V: CZO Stock Ticker

$43.8M Market capitalization as of April 20, 2016

62.6M Common shares outstanding

$10,667,000 Total sales for the full year 2015

$5,000,000 Total amount of grant-based-funding raised to date

Highest revenues, profits and cash flows reported in Company’s history for FY 2015

Value-Driving Milestones

30

Q1 2016 Q2 2016 Q3 2016 Q4 2016

Complete New Manufacturing Facility

Complete Commercial Scale-up of PGX

PGX Alliance Opportunities

Nutraceuticals and Pharmaceuticals

Beta Glucan: Conduct Safety Studies of High

Purity Beta Glucan in Oral Formulation

Beta Glucan: Commence Cholesterol Pilot

Clinical Trial

Avenanthramides: Anti-inflammatory Effect from

High Dose vs. Low Dose - Study Results

Complete Development of Functional Drink

30

www.ceapro.comTSX: CZO

Enhancing Life Through Nature

Corporate Presentation